Shareholder's Meeting
Notice is hereby given of the following matters to be reported and resolved at the 5th Ordinary General Meeting of Shareholders of Mitsubishi Tanabe Pharma Corporation.
| Date and time | 10:00 a.m., Friday, June 22, 2012 |
|---|---|
| Venue | Hilton Osaka hotel, 5th Floor, "Sakura" Meeting Room, 8-8, Umeda 1-chome, Kita-ku, Osaka, Japan |
Matters Reported:
- Reports on business review, consolidated statements, and non-consolidated statements for the 5th fiscal year (from April 1, 2011 to March 31, 2012)
- Reports on auditing report on consolidated statements from independent Auditor and Board of Auditors
The contents of the above were reported.
Matters Resolved:
| Resolution 1: | Distribution of retained earnings This item was approved and resolved as originally proposed. The year-end dividend was decided to be ￥20 per share. |
|---|---|
| Resolution 2: | Election of eight (8) Directors This item was approved and resolved as originally proposed. Eight Directors, namely, Mr. Michihiro Tsuchiya, Mr. Kuniaki Kaga, Mr. Kenichi Yanagisawa, Mr. Kenkichi Kosakai, Mr. Masayuki Mitsuka, Mr. Takashi Kobayashi, Mr. Shigehiko Hattori and Mr. Seishiro Yoshioka were reelected and assumed their offices. Mr. Shigehiko Hattori and Mr. Seishiro Yoshioka are Outside Directors. |
| Resolution 3: | Election of one (1) Substitute Auditor This item was approved and resolved as originally proposed. Mr. Hidetaka Tomita was elected as an Outside Substitute Auditor. |
